Ayala Pharmaceuticals, Inc. — Form D

Ayala Pharmaceuticals, Inc. of MONMOUTH JUNCTION, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2010-11-15. $835K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (40)

Showing 25 of 40 people.

NameRoleLocation
Thomas MooreDirectorFranklin, TN
Thomas MooreExecutive OfficerFranklin, TN
Richard BermanDirectorMerritt Island, FL
Mark J RosenblumExecutive OfficerHouston, TX
David SidranskyDirectorGermantown, MD
Andres A GutierrezExecutive OfficerMONMOUTH JUNCTION, NJ
Igor A GitelmanExecutive OfficerMONMOUTH JUNCTION, NJ
Pini A OrbachDirectorMONMOUTH JUNCTION, NJ
Murray A GoldbergDirectorMONMOUTH JUNCTION, NJ
Vered A Bisker-LeibDirectorMONMOUTH JUNCTION, NJ
Yuval A CabillyDirectorMONMOUTH JUNCTION, NJ
Bridget A MartellDirectorMONMOUTH JUNCTION, NJ
Roy A GolanExecutive OfficerMONMOUTH JUNCTION, NJ
Robert A SpiegelDirectorMONMOUTH JUNCTION, NJ
David A SidranskyDirectorMONMOUTH JUNCTION, NJ
Roni A AppelDirectorMONMOUTH JUNCTION, NJ
Ken A BerlinDirectorMonmouth Junction, NJ
Ken A BerlinExecutive OfficerMonmouth Junction, NJ
Kenneth BerlinDirectorMonmouth Junction, NJ
Kenneth BerlinExecutive OfficerMonmouth Junction, NJ
Samir KhleifDirectorMonmouth Junction, NJ
Igor GitelmanDirectorMonmouth Junction, NJ
Igor GitelmanExecutive OfficerMonmouth Junction, NJ
Roni AppelDirectorMonmouth Junction, NJ
James PattonDirectorMonmouth Junction, NJ

Other filings by this issuer (13)

FiledFormOfferingSold
2023-11-02D$434K$434K
2022-02-11D$4.8M$4.8M
2021-04-28D$11.1M$11.1M
2012-12-13D$10.0M
2012-06-06D$715K
2012-05-29D$4.5M
2012-02-24D$1.0M
2011-11-15D$2.0M
2011-05-27D$6.0M
2010-07-30D$7.5M$7.5M
2009-10-22D$50K
2009-10-05D$5.0M$5.0M
2009-10-01D$962K

More